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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not obese
patients have a better quality of life after undergoing gastric bypass rather than sleeve
gastrectomy.
STUDY DESIGN: A review of 3 randomized controlled trials (RCT) that were published after
2014.
DATA SOURCES: The 3 peer-reviewed randomized controlled trials were found through
PubMed. All studies were published in English.
OUTCOMES MEASURED: The outcome measured in these RCTs was overall change in
quality of life after sleeve gastrectomy and gastric bypass. This was done by patients responding
to questionnaires. Two articles Ignat et al. and Peterli et al. used the Gastrointestinal Quality of
Life Index and Murphy et al. used the physical functioning on the SF-36 subscale questionnaire.
RESULTS: The RCT performed by Murphy et al. showed significant positive change from
baseline in quality of life one year after surgery for both groups (P<0.001), but no significance
between the 2 different surgical interventions (P=0.41). Similarly, Ignat et al. also showed
improvement of quality life from baseline one year after surgery (P<0.001) and no significance
between the 2 groups (P=0.323). Lastly, Peterli et al. further supported the enhancement in
quality of life one year after surgery in both the gastric bypass and sleeve gastrectomy (P=0.003,
P=0.001) with no significant difference found between the 2 interventions (P=0.366).
CONCLUSION: The review of these 3 RCTs provides information on the ability of bariatric
surgery to improve QoL. Statical significance was noted for change from baseline in all 3 studies
with no significance between the 2 intervention groups of sleeve gastrectomy and gastric bypass.
Both types of surgery are effective ways to improve quality of life although sleeve gastrectomy
is not superior, but comparable, to gastric bypass.
KEY WORDS: obesity, bariatric surgery, quality of life
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INTRODUCTION
Obesity is a chronic condition where an individual has excess amounts of adipose tissue
and a state of low-grade inflammation. It can contribute to conditions like cardiovascular disease,
diabetes, and hypertension. Additionally, it contributes to metabolic dysfunction of glucose and
lipids as well as immune dysfunction.1 Research states the main reason for obesity is excessive
energy intake compared to expenditure, an imbalance in the caloric intake and output. There is
also genetic predisposition which can play a role. In other situations, endocrine disorders, as well
as medication, and psychiatric conditions can cause obesity. Hormones like leptin, ghrelin, and
insulin can contribute if they are imbalanced.2 Obesity can be a very serious risk factor to many
different conditions, predisposing individuals to future health issues. It has been shown to
decrease quality of life and increase risk for psychological disorders as well. 3
When it comes to treating the chronic condition, there are different methods that are used
depending on the patient’s BMI. The defining factors for BMI are as follows: overweight BMI:
>25-29.9 kg/m2, obese stage 1 BMI: 30-34.9 kg/m2, obese stage 2 BMI: 35-39.9 kg/m2, obese
stage 3 BMI: 40 kg/m2 or above. Evaluating the patient’s BMI and previous attempts on losing
the excess adipose tissue help to determine the treatment approach for the patient.
The first step for treatment in obese individuals is to change dietary intake, by altering
their caloric intake quantity as well as quality. Patients should consume less calories than they
are expending as well as calories that are high in nutrients to keep the body healthy. Along with
change in diet, patients need to increase their physical activity to burn more calories. This is done
through lifestyle modifications as well as beginning exercise routines or simply moving more
throughout the day.2 The next step in treatment for obese individuals is pharmaceuticals. Some
medications that are used for eliminating excess adipose tissue are Contrave, Lorcaserin,
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Qsymia, and Xenical.2 These can be used in combination with dietary restrictions and lifestyle
modifications for people who have not succeeded with them alone or have a higher BMI. The
final step to treatment for patients who have severe obesity is bariatric surgery. The different
surgical approaches are sleeve gastrectomy, gastric bypass, and adjustable gastric banding.2
Although all of the different treatments are options for obese individuals, the focus of this
paper is to compare 2 different surgical approaches, sleeve gastrectomy and gastric bypass.
Specifically, it will evaluate how each one of these surgical approaches affect the quality of life
in individuals one year post-operation. Quality of life (QoL) is extremely important for all
individuals and as stated is many times decreased in obese individuals.3 The surgical treatment
plans for assisting in weight loss have shown to improve quality of life in individuals and this
paper will evaluate if sleeve gastrectomy has greater improvements than gastric bypass.
The focus on treatment for obesity is pertinent to the current practice of healthcare
providers due to the high prevalence in society. Currently in the country, 39.8% of the population
over the age of 20 years old is obese.4 This number is also continuing to increase and many
patients that providers encounter are overweight or obese. This is relevant to practice due to the
high volume of patients that suffer from the disease as well as its consequences. Some of the
conditions that are associated with obesity are cancer, type 2 diabetes, heart disease, as well as
strokes.5 Because of such high prevalence as well as other medical conditions that can be caused
by increase in adipose tissue, it is essential that providers can give patients an effective treatment
plan to help control their body weight.
As well as being so common, the cost of the disease itself is very expensive. In 2008, it
was reported that the national average cost for patients that were obese and overweight was
113.9 billion dollars, obesity accounted for 98.1 billion dollars. That accounts for 5-10% of all
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medical costs in the United States healthcare system. 6 So, not only are there high numbers of
people that are living with the chronic disease, but the consequence of healthcare costs is also
affecting the healthcare system. Additionally, there were 11 million annual visits made in the
U.S. for obesity in 2012 for patients who were 20 years and older.7 These values show how much
the disease affects not only the patients, but also providers. Due to the large volume of
Americans suffering, it is pertinent for physician assistants and other healthcare providers to be
comfortable with treatment plans for their patients as well as have information to help decide the
best approach for them. This paper can assist in providing information to patients who are
seeking a surgical intervention as their treatment plan.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not obese patients
have a better quality of life after undergoing gastric bypass rather than a sleeve gastrectomy.
METHODS
Three RCTs were found via PubMed focusing on bariatric surgery in obese adults. In
search for relevant articles, population criteria was restricted to adult, obese patients. The
intervention that was used for the search criteria was sleeve gastrectomy and the comparison
group was gastric bypass surgery. Criteria for outcomes measures was restricted to overall
change in quality of life one year after the operation. The types of studies considered were
randomized controlled trials.
Keywords included were “obesity,” “sleeve gastrectomy,” “gastric bypass,” “quality of
life.” All articles were published in English. Articles were found through the PubMed database
and were selected based on the type of trial that was performed, relevance of the article to the
topic and the use of POEM outcomes that compared well to the other articles selected. Inclusion
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criteria for selecting articles consist of RCT, English, published after 2014, involved gastric
bypass and sleeve gastrectomy. The exclusion criteria for the article selection was articles
published before 2014, not assessing quality of life, and were not RCT. The summary of
statistics were reported by the mean change from baseline and p-value.
Table 1. Demographics & characteristics of included studies
Study

Type

#
Pts
100

Age
yrs
2545

Inclusion
Criteria
Aged 18-60,
BMI 40-60
kg/m2, no
contraindication
s to surgical
procedures or
anesthesia,
provided
consent, no
addiction

Ignat8
(2017)

RCT

Murphy9 Blin(2018)
ded
RCT

114

3954

Peterli10
(2017)

217

3154

Aged 20-55,
BMI 35-65
kg/m2, T2D
diagnosed for at
least 6 months,
committed to
follow-up,
surgical
candidate
Aged 18-65,
BMI >40 or
>35 kg/m2 with
one
comorbidity,
failure of
conservative
treatment for 2
years

RCT

Exclusion Criteria

W/D

Previous
13
gastrointestinal
procedure, hiatal
hernia larger than 2
cm, pregnancy,
immunosuppressed,
coagulopathy,
anemia,
malabsorptive
disease, psychiatric
pathology, angina
or cardiac failure,
MI
Postprandial C5
Peptide <350
pmol/L, T1D or
secondary diabetes,
pregnant, chronic
pancreatitis,
smoker, not suitable
for anesthesia, oral
steroid therapy
GERD, IBD, dense 14
adhesions of the
small bowel, need
for endoscopic
follow-up of the
duodenum, hiatal
hernia >4cm

Intervention
s
Laparoscopic
sleeve
gastrectomy
and
Laparoscopic
Roux-en-Y
gastric
bypass

Laparoscopic
sleeve
gastrectomy
and
laparoscopic
Roux-en-Y
gastric
bypass
Laparoscopic
sleeve
gastrectomy
and
laparoscopic
Roux-en-Y
gastric
bypass

4
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OUTCOMES MEASURED
The outcomes measured for all three articles is quality of life one year post-operation.
This was measured by Gastrointestinal Quality of Life Index in two articles and physical
functioning on the SF-36 subscale questionnaire in the other article. The Gastrointestinal Quality
of Life Index is a 0-4 scale survey, the higher score being a higher QoL, given to the patient to
evaluate their overall emotional function in 5 questions, social function (4 questions), 19
questions on gastrointestinal symptoms, treatment assessment (1 question), and physical function
(7 questions).8
RESULTS
Murphy et al.9 compared sleeve gastrectomy from gastric bypass in a randomized control
study to assess the differences in 2 types of bariatric surgery. Patients recruited for the study
were obese adult patients who have type 2 diabetes. More information about patient inclusion
and exclusion criteria can be found in Table 1. 58 patients were randomly assigned to receive the
laparoscopic sleeve gastrectomy and 56 patients were randomly assigned to the laparoscopic
gastric bypass group.9 Patients were evaluated prior and followed up for analysis at one year
post-operation. The study included 114 patients and a total of 5 patients were lost at follow-up.
Quality of life was measured from the five SF-36 subscales evaluation; one of the subscales
assesses physical functioning.9 This is the value that was used to evaluate the change in QoL for
patients who undergo bariatric surgery. A change from baseline was used to evaluate the
improvement or lack thereof in the 2 interventions. A student’s t-test or Mann-Whitney U test
were used to assess the between-group comparisons; a two-sided p-value <0.05 was considered
significant.9 The values were presented as means with standard deviations assessing the change
from their baseline rating on the QoL scale. The researchers found that for the group
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comparisons one year post-operation there was no statistically significant difference (P=0.41)
between the sleeve gastrectomy and gastric bypass groups. That said, the change from baseline in
both groups was significant (P<0.001).9 Based on the evaluation of change from baseline, there
is a large treatment effect in both sleeve gastrectomy and gastric bypass (Table 2).
Table 2. Murphy et al. mean change from baseline assessing QoL ± SD9
Change from
p-value
p-value between
baseline
groups
Gastric Bypass
24.00 ± 31.45
P <0.001*
P=0.41*
Sleeve
19.51 ± 23.20
P <0.001*
Gastrectomy
*= Statically significant <0.05
Ignat et al.8 is a randomized control trial that is evaluating differences between gastric
bypass surgery and sleeve gastrectomy in University Hospital of Strasbourg, France. 105 patients
were chosen based on the inclusion and exclusion criteria as stated in Table 1. Patients were
randomized by closed envelopes into either the Roux-en-Y gastric bypass intervention group or
the sleeve gastrectomy intervention group. Patients underwent the surgical procedure and were
assessed one year later for change in quality of life since the surgery.8 As stated, 105 patients
began the study, but 8 patients were lost at follow-up. Additional interventions were needed in
13% of the gastric bypass group and 4% in the sleeve gastrectomy group.8 In the gastric bypass
group interventions included a follow-up laparotomy, one had a postoperative bleed, an internal
hernia repair, and a patient got peritonitis. Additionally, 3 patients from the sleeve gastrectomy
group converted to the gastric bypass group. Quality of life was assessed in each intervention
group and was presented as mean change from baseline and standard deviation. Statistical
analysis of EWL was used with time as the level 1 predictor and treatment group was the level 2
predictor.8 Then, the student’s t-test with Bonferroni correction for multiple comparisons was
used for the between group comparison, along with the Wilcoxon-Mann-Whitney test. For the
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categorical variable p-values, the Fisher’s exact test was used and p<0.05 was considered
significantly significant. With that said, the change from baseline for both the sleeve gastrectomy
and gastric bypass interventions were both significant (p<0.001) as seen in Table 3.8
Additionally, with the values listed in Table 3 representing mean change from baseline, there
was a large treatment effect. That said, when comparing change between the 2 interventions,
there was no statistical significance (p=0.323).8
Table 3. Ignat et al. mean change from baseline assessing QoL8
Baseline

Gastric Bypass
96.4 ± 16.0
Sleeve
90.7 ± 16.3
Gastrectomy
*= Statically significant <0.05

1-year post-op

p-value

113.8 ± 16.4
113.9 ± 17.1

p <0.001*
p <0.001*

Change
from
baseline
17.4
23.2

p-value
between
groups
p=0.323*

Peterli et al.10 present a randomized control trial comparing change in QoL among
patients who receive bariatric surgery, either sleeve gastrectomy or gastric bypass. In this study,
125 patients were divided into 2 different intervention groups to evaluate the effects of the
different surgical methods. At the one-year follow-up 8 patients were lost and therefore excluded
from the data. One patient crossed over to the sleeve gastrectomy group and 7 were not operated
on before the deadline.10 Patients were selected based on the inclusion and exclusion criteria that
are described in Table 1. After surgery was performed, 9 patients from the sleeve gastrectomy
group needed additional surgeries from complications like gallstones, requiring cholecystectomy.
Some patients also converted over to the gastric bypass group because they did not lose
sufficient weight.10 From the gastric bypass group 16 patients needed additional surgery for
conditions like hernias, small bowel obstructions, and infections. One patient needed a resection
of Meckel diverticulum. Data from this study was evaluated with IBM SPSS for Windows and
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student t-test, Fisher exact two-sided tests, and chi-square test.10 The statistical significance was
set at p<0.05. For the purpose of this paper, the focus is on evaluation of QoL one-year after
surgery, and Peterli et al. used the Gastrointestinal Quality of Life Index to do so. From the data
collected through the questionnaires it was found that both of the intervention groups
significantly improved QoL (p=0.001, p=0.003).10 This is seen through mean values and
standard deviations represented as change from baseline (Table 4). Besides the change after oneyear, between group change was also compared and this was not statistically significant
(p=0.366).10
Table 4. Peterli et al. mean change from baseline assessing QoL10
Baseline

Gastric Bypass
99.3 ± 20.6
Sleeve
100.0 ± 20.6
Gastrectomy
*= Statically significant <0.05

1-year post-op

p-value

Change from
baseline

128.5 ± 9.3
126.3 ± 13.4

p <0.003*
p <0.001*

29.2
26.3

p-value
between
groups
p=0.366*

DISCUSSION
Obesity is a debilitating disease that increases morbidity and mortality in many
individuals in the United States. This chronic condition has many negative effects on a patient’s
health and causes deterioration of multiple body systems like the heart, kidney, nervous, and
musculoskeletal system. When considering bariatric surgery, certain relative contraindications
need to be considered. There are no absolute contraindications to surgery, but weighing benefit
versus risk for certain patients is essential. Careful decision making should be present in patients
with active cancer treatment, drug/alcohol dependency, severe heart failure, and end-stage lung
disease.11 Bariatric Surgery is indicated in patients with BMI >40 kg/m2 or >35 kg/m2 with comorbidities. Obesity-related comorbidities include hypertension, obstructive sleep apnea, urinary
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incontinence, GERD, asthma, arthritis, diabetes, and hyperlipidemia.11 All of these indications
and contraindications need to be considered in patients who are interested in discussing bariatric
surgery as an option for weight loss. Some complications may also occur as previously noted by
research. Surgical interventions have led to anastomotic leaks, surgical site infection, internal
hernias and ulcers, and injuries to internal organs. Some more rarer complications that have been
noted are myocardial infarctions, hemorrhages, and pulmonary embolism.11 As well as
indications and contraindications, it is also important to be aware of complications that can occur
from the procedure. That said, there are many positive outcomes that come from the different
interventions and surgery can be beneficial to the patient and their ability to live a healthy life.
This systematic review gathered research to see benefits that result from a patient
receiving a bariatric surgery intervention, specifically change in overall quality of life. All 3 of
the studies focused on the mean change from baseline one-year post-operation for individuals
who volunteered to have gastric bypass or sleeve gastrectomy. All articles had consistent data
about changes in quality of life for both interventions. The 3 articles assessed by Murphy et al.,9
Peterli et al.,10 and Ignat et al.8 had data to support that there was improvement in quality of life
for patients in the sleeve gastrectomy and the gastric bypass groups. The purpose of this paper
was to assess if sleeve gastrectomy produced a higher improvement of quality of life than the
gastric bypass. From the information found, sleeve gastrectomy does not produce a QoL greater
than gastric bypass. Data showed no statistically significant difference in change between
groups, so they both may overall have similar effects on QoL.8-10
Along with the conclusions drawn from each study, there were also limitations noted by
the researchers. Murphy et al.9 notes that the lack of a control group could be a limitation of the
study, but from previous data, surgery has superior outcomes then medical interventions. Other
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limitations are the small sample size and the fact that the procedure only takes place in one
center, making the conclusions more difficult to generalize. Additionally, no worst-case analysis
was done, so some of the results could be skewed. Peterli et al.10 states that limitations to the
research done by them includes the fact that there were a low number of diabetic patients in each
group, so they are unsure how that affects the outcome. Also, they note that there were numerous
reoperation rates, a total of 15, which could also be a limitation to the data they collected.
Blinding was not used in this study and outcomes were still measured subjectively, therefore
results could be bias because participants have more information that can sway their decision
making. Lastly, Ignat et al.8 reports that limitations to their study could include the high number
of patients that were lost to follow-up because the hospital was further away for many people. As
well as, there were many more women than men in the study, so sex could be another limitation.
Intention to treat analysis was not completed as well as worst case analysis which could both
have altered the outcomes and made the results less reliable. When conducting the research, the
inclusion criteria focused on obese individuals, but not any other co-morbidities. This could be a
limitation due to the fact that studies used different inclusion criteria for patients and other
coexisting illnesses could play a role in the patient outcomes. This may change the outcomes
slightly for how individuals view their QoL. Additionally, the focus of QoL is a subjective
measure, therefore many outside factors besides the surgery could affect how people respond to
the questionnaire. This could be a limitation because there are other life factors that play a role in
deciding how a patient may feel on that day they are assessing their QoL.
CONCLUSION
From the information collected from the 3 different randomized control trials in this
systematic review, it can be concluded that bariatric surgery is beneficial for improvements in
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QoL. Specifically, sleeve gastrectomy does not have a greater improvement than gastric bypass
intervention. All 3 studies concluded that there is no statistically significant difference in the
improvement of overall QoL between the study groups. This is supported by data from baseline
QoL and change one-year post-operation in trials conducted by Murphy et al.,9 Peterli et al.,10
and Ignat et al.8 Therefore, each intervention can be successfully used for assistance in weight
loss in adult obese patients looking to enhance their QoL.
Future studies could include an additional intervention group that consists of an
adjustable band intervention. It would be interesting to see how other types of surgery compare
to the 2 more widely used methods. This information could be useful for individuals who are
eligible for bariatric surgery and are looking for information to assist in their decision making for
choosing a procedure. Additionally, considering a control group for comparison may be
beneficial as stated by Murphy et al.,9 as long as it remains ethical. Other comparison groups to
compare to may also include a group that focuses on lifestyle changes including increasing
exercise and dietary alterations as well as pharmaceutical groups. As stated when evaluating
limitations, future studies can include worst case analyses and intention to treat analyses to
ensure validity of the data that is presented. Additionally, adding blinding to each protocol can
help to reduce bias. The more studies that are carried out could help to generalize the information
to all patients that are eligible for bariatric surgery, this information can be beneficial to patients
who may not be aware of all their options and the positive outcomes that come along with
choosing a certain type of intervention over another.

References
1.Redinger RN. The pathophysiology of obesity and its clinical manifestations. Gastroenterol
Hepatol. 2007;3(11)865-863.
2. Zhang Y, Liu J, Yao J, et al. Obesity: Pathophysiology and intervention. Nutrients.
2014;6(11):5153-5183. doi:10.3390/nu6115153.
3.Vallis M. Quality of life and psychological well-being in obesity management: Improving the
odds of success by managing distress. Int J Clin Pract. 2016;70(3)196-205. doi:
10.1111/ijcp.12765.
4.National Center for Health Statistic- Obese and Overweight. CDC. 2020.
https://www.cdc.gov/nchs/fastats/obesity-overweight.htm. Accessed September 29, 2020.
5.Adult Obesity Facts- Obesity is a common, serious and costly disease. CDC. 2020.
https://www.cdc.gov/obesity/data/adult.html. Accessed September 29, 2020
6.Tsai AG, Williamson DF, & Glick HA. Direct medical cost of overweight and obesity in the
United States: A quantitative systematic review. Obes Rev. 2011;12(1):50-61.
doi: 10.1111/j.1467-789X.2009.00708.x.
7.Products- Data Briefs- Number 237. CDC. 2016.
https://www.cdc.gov/nchs/products/databriefs/db237.htm. Accessed September 29, 2020.
8.Ignat M, Vix M, Imad I, et al. Randomized trial of Roux-en-Y gastric bypass versus sleeve
gastrectomy in achieving excess weight loss. Br J Surg. 2017;104(3):248-256. doi:
10.1002/bjs.10400.
9.Murphy R, Clarke MG, Evennett, NJ, et al. Laparoscopic sleeve gastrectomy versus banded
roux-en-y-gastric bypass for diabetes and obesity: A prospective randomized double-blind trial.
Obes Surg. 2018;28(2):293-302. doi: 10.1007/s11695-017-2872-6.
10.Peterli R, Wolnerhanssen BK, Vetter D, et al. Laparoscopic sleeve gastrectomy versus rouxy-gastric bypass for morbid obesity--- 3-year outcomes of the prospective randomized Swiss
multicenter bypass or sleeve study. Ann Surg. 2017;265(3)466-473.
doi:10.1097/SLA.0000000000001929.
11. Stahl JM & Malhotra S. Obesity surgery indications and contraindications. StatPearls
Publishing. 2020. https://www.ncbi.nlm.nih.gov/books/NBK513285/. Accessed November 29,
2020.

